New insights emerge from ongoing analyses of GA studies, enhancing AMD treatment strategies and patient management at Bay Area Retina Associates.

Discover new safety insights on Syfovre for geographic atrophy treatment, as Roger A. Goldberg highlights promising long-term data at ASRS 2025.

New findings reveal Syfovre may protect central vision in macular degeneration patients, delaying vision loss and enhancing treatment strategies.

More than 60 companies pledged to improve healthcare technology during a White House “Make Health Tech Great Again” event hosted as part of the Centers for Medicare & Medicaid Services Health Tech ...

New findings reveal that early treatment with Syfovre significantly improves vision preservation in geographic atrophy ...

PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

Cigna has sold its Medicare businesses and slashed the number of people it covers in its ACA plans by more than half.

CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation ...

Surveys of American Society of Retina Specialists members have revealed a preference for physicians’ experiences with new ...

A session on a surgery technique to treat macular holes using amniotic membrane transplants will be one of the highlights at ...

There will be a greater focus on surgical topics at the 2025 meeting of the American Society of Retina Specialists, compared ...

Interest in surgical advancements such as retinal detachment repair is driven by the need for balance within the field and a ...